Healthcare Trust of America Closes Over $2.6 Billion in 2Q Investments and Raises $2.9 Billion of Capital

SCOTTSDALE, ARIZONA—July 12, 2017—Healthcare Trust of America, Inc. (NYSE:HTA), the largest owner and operator of medical office buildings in the United States, announced that during the second quarter, it had closed investments totaling over $2.6 billion including 93 properties aggregating 6.2 million square feet.  Approximately 91% of the acquired GLA was located in HTA’s existing key markets.

As of the end of the second quarter, HTA had closed the majority of the $2.75 billion Duke Realty (“Duke”) medical office building portfolio announced in May 2017. Of that portfolio, HTA has closed 69 of the properties totaling approximately $2.2 billion and 4.9 million square feet of GLA. Another 11 properties totaling $495 million have been excluded from the transaction, primarily as a result of executed rights of first refusal. The remaining 3 properties and a land parcel, totaling $138 million and 245k square feet of GLA are expected to close in July.

In addition to the Duke transaction, HTA has invested approximately $391 million in 24 medical office buildings, totaling 1.3 million square feet during the second quarter.  This brings HTA’s total first half closed investments to $2.6 billion at an average cap rate of approximately 5% before any synergies, which consists of over 6.3 million square feet of GLA comprised primarily of on-campus, Class A medical office buildings located in HTA’s key, gateway markets.

To finance these transactions, HTA has raised over $2.9 billion in debt and equity capital including:

  • $1.7 billion in common equity, net, including marketed transactions and its ATM, issuing approximately 59 million shares;
  • $900 million of senior unsecured bonds at 3.4% average interest rate and duration of 7.8 years; and
  • $286 million of secured, seller financing at 4.0% per year, maturing in three equal annual installments beginning in 2018.


About HTA

Healthcare Trust of America, Inc. (NYSE: HTA) is the largest dedicated owner and operator of medical office buildings in the United States, based on gross leasable area.  We provide the real estate infrastructure for the integrated delivery of healthcare services in highly desirable locations.  Over the last decade, we have invested over $6.8 billion primarily in medical office buildings and other healthcare assets comprising approximately 24 million square feet of GLA.  Our investments are targeted in key markets that we believe have superior healthcare demographics that support strong, long-term demand for medical office space.  We have achieved, and continue to achieve, critical mass within these key markets by expanding our presence through accretive acquisitions, and utilizing our in-house operating expertise through our regionally located property management and leasing platform.

Founded in 2006 and listed on the New York Stock Exchange in 2012, HTA has produced attractive returns for its stockholders that we believe have significantly outperformed the S&P 500 and US REIT indices.  More information about HTA can be found on the Company’s website at


Forward-Looking Language

This press release contains certain forward-looking statements.  Forward-looking statements are based on current expectations, plans, estimates, assumptions and beliefs, including expectations, plans, estimates, assumptions and beliefs about HTA, stockholder value and earnings growth.

The forward-looking statements included in this press release are subject to numerous risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements.  Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond HTA’s control.  Although HTA believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, HTA’s actual results and performance could differ materially and in adverse ways from those set forth in the forward-looking statements.  Factors which could have a material adverse effect on HTA’s operations and future prospects include, but are not limited to:

  • changes in economic conditions affecting the healthcare property sector, the commercial real estate market and the credit market;
  • competition for acquisition of medical office buildings and other facilities that serve the healthcare industry;
  • economic fluctuations in certain states in which HTA’s property investments are geographically concentrated;
  • retention of HTA’s senior management team;
  • financial stability and solvency of HTA’s tenants;
  • supply and demand for operating properties in the market areas in which HTA operates;
  • HTA’s ability to acquire real properties, and to successfully operate those properties once acquired;
  • changes in property taxes;
  • legislative and regulatory changes, including changes to laws governing the taxation of REITs and changes to laws governing the healthcare industry;
  • fluctuations in reimbursements from third party payors such as Medicare and Medicaid;
  • changes in interest rates;
  • the availability of capital and financing;
  • restrictive covenants in HTA’s credit facilities;
  • changes in HTA’s credit ratings;
  • HTA’s ability to remain qualified as a REIT;
  • changes in accounting principles generally accepted in the United States of America, policies and guidelines applicable to REITs;
  • delays in liquidating defaulted mortgage loan investments; and
  • the risk factors set forth in HTA’s most recent Annual Report on Form 10-K and in HTA’s most recent Quarterly Reports on Form 10-Q.

Forward-looking statements speak only as of the date made.  Except as otherwise required by the federal securities laws, HTA undertakes no obligation to update any forward-looking statements to reflect the events or circumstances arising after the date as of which they are made.  As a result of these risks and uncertainties, readers are cautioned not to place undue reliance on the forward-looking statements included in this press release or that may be made elsewhere from time to time by, or on behalf of, HTA.